Goldstein David S. 4
4 · Obagi Medical Products, Inc. · Filed Mar 15, 2012
Insider Transaction Report
Form 4
Goldstein David S.
Executive Vice President
Transactions
- Exercise/Conversion
Common Stock
2012-03-13$5.86/sh+16,666$97,663→ 16,666 total - Sale
Common Stock
2012-03-13$12.51/sh−16,666$208,483→ 0 total - Exercise/Conversion
Employee Stock Option (right to buy)
2012-03-13−16,666→ 0 totalExercise: $5.86Exp: 2019-03-03→ Common Stock (16,666 underlying)
Footnotes (1)
- [F1]Fully vested and immediately exercisable.